Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 11679975)

Published in Hepatology on November 01, 2001

Authors

J Hou1, Z Wang, J Cheng, Y Lin, G K Lau, J Sun, F Zhou, J Waters, P Karayiannis, K Luo

Author Affiliations

1: Department of Infectious Disease, Nanfang Hospital, The First Medical College of PLA, Guangzhou, China. jlhou@fimmu.edu.cn

Articles citing this

Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci (2005) 2.61

Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion. Virol J (2010) 1.47

Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants. J Virol (2006) 1.39

Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China. J Virol (2013) 1.31

Molecular testing in the diagnosis and management of chronic hepatitis B. Clin Microbiol Rev (2007) 1.20

Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana. J Clin Microbiol (2010) 1.20

Hepatitis B virus S gene escape mutants. Asian J Transfus Sci (2007) 1.14

Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene. J Virol (2004) 1.13

The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J Clin Microbiol (2007) 1.12

Clinical implications of hepatitis B virus mutations: recent advances. World J Gastroenterol (2014) 1.08

Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clin Infect Dis (2008) 1.04

Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection. Saudi J Gastroenterol (2009) 1.03

Impairment of hepatitis B virus virion secretion by single-amino-acid substitutions in the small envelope protein and rescue by a novel glycosylation site. J Virol (2010) 1.02

Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance. J Virol (2012) 0.99

Pathogenesis of occult chronic hepatitis B virus infection. World J Gastroenterol (2011) 0.97

Impaired virion secretion by hepatitis B virus immune escape mutants and its rescue by wild-type envelope proteins or a second-site mutation. J Virol (2012) 0.90

Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface protein. Hepatol Int (2010) 0.90

Spontaneous HBsAg loss in Korean patients: relevance of viral genotypes, S gene mutations, and covalently closed circular DNA copy numbers. Clin Mol Hepatol (2014) 0.89

Potential mutations associated with occult hepatitis B virus status. Hepat Mon (2014) 0.87

Occult HBV infection among Egyptian hepatocellular carcinoma patients. Virol J (2011) 0.86

Occult Hepatitis B (OBH) in Clinical Settings. Hepat Mon (2012) 0.86

Prediction of conformational changes by single mutation in the hepatitis B virus surface antigen (HBsAg) identified in HBsAg-negative blood donors. Virol J (2010) 0.85

Hepatitis B virus genotypes and evolutionary profiles from blood donors from the northwest region of China. Virol J (2009) 0.84

Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach. World J Gastroenterol (2013) 0.84

The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile". Eur J Clin Microbiol Infect Dis (2011) 0.84

Occult hepatitis B in blood donors: a description of two cases. Blood Transfus (2010) 0.83

Clinical significance of hepatitis B surface antigen mutants. World J Hepatol (2015) 0.82

Genetic variation of hepatitis B virus and its significance for pathogenesis. World J Gastroenterol (2016) 0.82

Hepatitis B surface gene 145 mutant as a minor population in hepatitis B virus carriers. BMC Res Notes (2012) 0.81

Hepatitis B surface antigen variant with multiple mutations in the a determinant in an agammaglobulinemic patient. J Clin Microbiol (2004) 0.81

Ultradeep Sequencing for Detection of Quasispecies Variants in the Major Hydrophilic Region of Hepatitis B Virus in Indonesian Patients. J Clin Microbiol (2015) 0.81

Prevalence and molecular analysis of occult hepatitis B virus infection isolated in a sample of cryptogenic cirrhosis patients in iran. Oman Med J (2014) 0.79

Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay. Hepatol Int (2012) 0.79

Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection. PLoS One (2016) 0.78

Clinical significance of occult hepatitis B infection in progression of liver disease and carcinogenesis. J Cancer (2013) 0.78

A novel stop codon mutation in HBsAg gene identified in a hepatitis B virus strain associated with cryptogenic cirrhosis. World J Gastroenterol (2003) 0.77

Antigenic and immunogenic changes due to mutation of s gene of HBV. World J Gastroenterol (2004) 0.76

Yeast expression and DNA immunization of hepatitis B virus S gene with second-loop deletion of alpha determinant region. World J Gastroenterol (2004) 0.76

Infection with hepatitis B virus carrying novel pre-S/S gene mutations in female siblings vaccinated at birth: two case reports. J Med Case Rep (2010) 0.76

Mutations associated with occult hepatitis B in HIV-positive South Africans. J Med Virol (2014) 0.76

Sequence variations of full-length hepatitis B virus genomes in Chinese patients with HBsAg-negative hepatitis B infection. PLoS One (2014) 0.76

Investigation of occult hepatitis B virus infection in anti-hbc positive patients from a liver clinic. PLoS One (2015) 0.76

HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients. Antivir Ther (2016) 0.75

Molecular Characterization of Pre-Core/Core and S Region of Hepatitis B Virus in Hemodialysis Patients With Occult Hepatitis B Infection. Jundishapur J Microbiol (2015) 0.75

Occult hepatitis B virus infection: influence of S protein variants. Virol J (2016) 0.75

Genetic variation of occult hepatitis B virus infection. World J Gastroenterol (2016) 0.75

Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis. Hepat Mon (2016) 0.75

Update on occult hepatitis B virus infection. World J Gastroenterol (2016) 0.75

Articles by these authors

The sequence of the human genome. Science (2001) 101.55

The Biomolecular Interaction Network Database and related tools 2005 update. Nucleic Acids Res (2005) 12.94

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest (1999) 8.38

Cereal genome evolution. Grasses, line up and form a circle. Curr Biol (1995) 8.33

Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell (2001) 8.09

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet (2014) 8.04

SIR2 and SIR4 interactions differ in core and extended telomeric heterochromatin in yeast. Genes Dev (1997) 7.81

Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell (1996) 7.70

Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science (1999) 7.51

Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26

Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial. Ann Intern Med (1998) 7.26

The Y-family of DNA polymerases. Mol Cell (2001) 6.49

A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology (2007) 5.86

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet (2001) 5.80

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science (1996) 5.55

Regulation of PTEN transcription by p53. Mol Cell (2001) 5.44

Genetic diversity and disease control in rice. Nature (2000) 5.34

Vaccine-induced escape mutant of hepatitis B virus. Lancet (1990) 5.31

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet (1989) 5.16

The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature (2001) 5.14

Circulating activated endothelial cells in sickle cell anemia. N Engl J Med (1997) 5.13

An internal control for routine diagnostic PCR: design, properties, and effect on clinical performance. J Clin Microbiol (1998) 4.58

A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3' end. Mol Cell Biol (1999) 4.51

Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med (1999) 4.44

Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. Proc Natl Acad Sci U S A (1984) 4.41

Transient simulation of last deglaciation with a new mechanism for Bolling-Allerod warming. Science (2009) 4.20

Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest (2000) 4.16

Proximal impact of two first-grade preventive interventions on the early risk behaviors for later substance abuse, depression, and antisocial behavior. Am J Community Psychol (1999) 3.98

Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med (2000) 3.92

Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol (2001) 3.87

Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation (2000) 3.82

Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc Natl Acad Sci U S A (1996) 3.78

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet (2002) 3.67

Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass. Am J Physiol (1998) 3.65

Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem (2000) 3.34

Control of pollen tube tip growth by a Rop GTPase-dependent pathway that leads to tip-localized calcium influx. Plant Cell (1999) 3.32

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst (2001) 3.28

Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem (2001) 3.24

Understanding the clinical dilemmas that shape medical students' ethical development: questionnaire survey and focus group study. BMJ (2001) 3.23

Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene (2006) 3.18

Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science (1984) 3.17

Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13

Regulation of imprinted X-chromosome inactivation in mice by Tsix. Development (2001) 3.12

Heparin protects basic and acidic FGF from inactivation. J Cell Physiol (1986) 3.09

Integrated human genome-wide maps constructed using the CEPH reference panel. Nat Genet (1994) 3.06

Tannins and human health: a review. Crit Rev Food Sci Nutr (1998) 3.03

Evidence to implicate translation by ribosomes in the mechanism by which nonsense codons reduce the nuclear level of human triosephosphate isomerase mRNA. Proc Natl Acad Sci U S A (1993) 2.98

The action of proteolytic enzymes on N,N-dimethyl proteins. Basis for a microassay for proteolytic enzymes. J Biol Chem (1969) 2.94

The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity (2000) 2.93

Nanostructured high-strength molybdenum alloys with unprecedented tensile ductility. Nat Mater (2013) 2.90

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med (2001) 2.87

A novel class of eukaryotic zinc-binding proteins is required for disease resistance signaling in barley and development in C. elegans. Cell (1999) 2.86

Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med (1999) 2.84

HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia (2010) 2.83

Rho GTPase function in tumorigenesis. Biochim Biophys Acta (2009) 2.81

Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP. Nat Genet (2001) 2.75

Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr (2000) 2.71

Reversal of resistance to Bacillus thuringiensis in Plutella xylostella. Proc Natl Acad Sci U S A (1994) 2.68

SIDS and the toxic gas theory revisited. N Z Med J (1998) 2.68

Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology (1995) 2.67

Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ (1998) 2.64

Different forms of TFIIH for transcription and DNA repair: holo-TFIIH and a nucleotide excision repairosome. Cell (1995) 2.58

The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev (1996) 2.58

Molecular characterization and transcriptional analysis of type 8 capsule genes in Staphylococcus aureus. J Bacteriol (1997) 2.58

T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57

Unique TATA-binding protein-containing complexes and cofactors involved in transcription by RNA polymerases II and III. EMBO J (1993) 2.56

The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery. Genet Epidemiol (2011) 2.54

Hormonal changes in the grains of rice subjected to water stress during grain filling. Plant Physiol (2001) 2.52

Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis (2013) 2.52

Clinical manifestations and diagnosis of acute pyrethroid poisoning. Arch Toxicol (1989) 2.50

Sleep patterns and total mortality: a 12-year follow-up study in Japan. J Epidemiol (2000) 2.49

Structure of the Mad2 spindle assembly checkpoint protein and its interaction with Cdc20. Nat Struct Biol (2000) 2.49

Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology (2006) 2.48

p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat Genet (1995) 2.47

Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages. EMBO J (1998) 2.45

Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature (1995) 2.43

Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J (1995) 2.41

The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions. Cell (2000) 2.41

Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med (1998) 2.40

Transcriptional regulation of human apolipoprotein genes ApoB, ApoCIII, and ApoAII by members of the steroid hormone receptor superfamily HNF-4, ARP-1, EAR-2, and EAR-3. J Biol Chem (1992) 2.39

Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res (1997) 2.38

Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J Biol Chem (2000) 2.37

Development of Bacillus thuringiensis CryIC Resistance by Spodoptera exigua (Hubner) (Lepidoptera: Noctuidae). Appl Environ Microbiol (1995) 2.36

Fire and flood management of coastal swamp enabled first rice paddy cultivation in east China. Nature (2007) 2.36

Pax3 modulates expression of the c-Met receptor during limb muscle development. Proc Natl Acad Sci U S A (1996) 2.35

Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol (2000) 2.33

Proximal sequence element-binding transcription factor (PTF) is a multisubunit complex required for transcription of both RNA polymerase II- and RNA polymerase III-dependent small nuclear RNA genes. Mol Cell Biol (1995) 2.33

Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene (1999) 2.33

The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol (2001) 2.32

Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1. EMBO J (2001) 2.32

Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc Natl Acad Sci U S A (1996) 2.31

Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev (1999) 2.31

TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol (2001) 2.28

Regional specialization in human nuclei: visualization of discrete sites of transcription by RNA polymerase III. EMBO J (1999) 2.28

Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol (1993) 2.27

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation (2001) 2.27

Passive smoking and lung cancer. Lancet (1983) 2.27